ORIGIN AND PREVENTION OF ONYCHOMYCOSIS: CLINICAL-PHYSIOLOGICAL AND PROPHYLAXIS APPROACHES
Ключевые слова:
onychomycosis, nail fungus, dermatophytes, pathogenesis, preventionАннотация
This article systematically analyzes the origin, development mechanisms and prevention of onychomycosis based on modern scientific sources. The study sheds light on the main etiological factors leading to fungal damage to the nail plate, in particular, the biological properties of dermatophytes, yeast-like and non-dermatophyte molds. The interrelationship of the physiological state of the nail tissue, local blood circulation, immune system activity and environmental factors in the pathogenesis of onychomycosis is shown.
The article also analyzed the risk factors contributing to the development of the disease: old age, diabetes, immunodeficiency, poor hygiene, and prolonged use of closed shoes. Special attention was paid to prevention issues, and the importance of personal hygiene, shoe and nail care, the use of local antifungal agents, control of chronic diseases, and a healthy lifestyle were scientifically explained.
The results of the systematic review show that a comprehensive approach to the prevention of onychomycosis, combining medical, hygienic, and preventive measures, is of great importance in reducing the spread of the disease and reducing the risk of relapse. This article is of scientific and practical importance for dermatologists, preventive medicine, and general practitioners
Библиографические ссылки
1. World Health Organization. Fungal Infections Report. Geneva: WHO Press; 2022. 96 p.
2. Gupta AK, Foley KA, Versteeg SG. New antifungal agents for onychomycosis. Journal of the European Academy of Dermatology and Venereology. 2018;32(6):910–918.
3. Hay RJ. Fungal infections: epidemiology and management. The Lancet. 2017;389(10082):2066–2078.
4. Elewski BE. Onychomycosis: pathogenesis, diagnosis and management. Clinical Dermatology. 2019;37(2):179–186.
5. Scher RK, Daniel CR. Nails: Diagnosis, Therapy, Surgery. 3rd ed. New York: Elsevier; 2016. 432 p.
6. Tosti A, Piraccini BM. Treatment strategies for onychomycosis. Dermatologic Clinics. 2020;38(3):257–264.
7. Baran R, Hay RJ, Tosti A, Haneke E. Onychomycosis: The Current Approach to Diagnosis and Therapy. Boca Raton: CRC Press; 2018. 368 p.
8. Gupta AK, Foley KA. Evidence-based update on diagnosis and management of onychomycosis. Journal of the American Academy of Dermatology. 2015;73(5):819–831.
9. Nenoff P, Krüger C, Ginter-Hanselmayer G. Mycology of onychomycosis. Mycoses. 2019;62(2):108–116.
10. Odds FC. Candida Infections: An Overview. Berlin: Springer; 2017. 221 p.
11. Summerbell RC, Kane J. Non-dermatophyte mould onychomycosis. Medical Mycology. 2016;54(4):361–373.
12. Monod M, Feuermann M. Pathogenesis of dermatophyte infections. Fungal Genetics and Biology. 2018;110:15–22.
13. Peres NTA, Maranhão FCA, Rossi A. Virulence factors of dermatophytes. Frontiers in Microbiology. 2019;10:162.
14. Schaller M, Borelli C. Immunopathogenesis of fungal nail infections. Mycoses. 2020;63(6):563–571.
15. Romani L. Immunity to fungal infections. Nature Reviews Immunology. 2017;17(9):540–554.
16. Lipner SR, Scher RK. Onychomycosis: clinical overview. Journal of the American Podiatric Medical Association. 2019;109(1):6–12.
17. Nenoff P, Krüger C. Advances in the treatment of onychomycosis. Mycoses. 2021;64(4):403–414.
18. Gupta AK, Stec N. Epidemiology of onychomycosis. British Journal of Dermatology. 2017;176(3):722–730.
19. Elewski BE, Tosti A. Risk factors and prevention of onychomycosis. Dermatologic Therapy. 2018;31(5):e12656.
20. Gupta AK, Skinner AR. Onychomycosis in diabetic patients. Diabetes Care. 2016;39(5):794–800.
21. Perfect JR. Fungal infections in immunocompromised patients. Clinical Infectious Diseases. 2020;71(6):1541–1549.
22. Sigurgeirsson B, Baran R. Prevention of onychomycosis. Journal of the European Academy of Dermatology and Venereology. 2019;33(4):626–630.
23. Hay RJ. Superficial fungal infections. Mycoses. 2018;61(Suppl 1):2–6.
24. Scher RK, Tavakkol A. Clinical management of nail fungal infections. Dermatologic Clinics. 2017;35(2):199–205.
25. Tosti A, Hay RJ. Treatment of onychomycosis: new trends. Journal of Dermatological Treatment. 2020;31(6):540–546.
26. Nenoff P, Krüger C. Epidemiology and therapy of onychomycosis. Mycoses. 2016;59(7):381–390.
27. Calder PC. Nutrition and immune response. Nutrients. 2020;12(1):1–19.
28. Lipsky BA, Hoey C. Foot infections in diabetic patients. Clinical Infectious Diseases. 2016;63(1):123–130.
29. Gupta AK, Versteeg SG. New perspectives on onychomycosis. Journal of Fungi. 2021;7(5):343.
30. Baran R, Tosti A. Practical aspects of onychomycosis management. Dermatology Practical & Conceptual. 2022;12(3):e2022154
